Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Lispro Low Mixture vs Glargine in T2D
NCT00036504Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2001
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin lispro in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Aug 2001; status: completed.
02
Drugs
insulin lispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00036504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00036504.